Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Syngene International Ltd

Pharmaceuticals & Biotechnology | Small Cap

Syngene International Ltd Health Insights
Health Score : 7.44Health Score : 7.44

Syngene International Ltd demonstrates a mixed financial performance. The company showcases robust solvency, growth, coverage, and profitability, indicating financial stability and efficient management. Its growth is fueled by increasing revenues and operating profits. However, liquidity and efficiency pose challenges. The company's financial ratios also indicate areas needing attention. While the company excels in key areas, addressing these weaknesses could enhance its overall financial health and competitive position in the healthcare services sector. Syngene's high scores in solvency, growth, coverage, and profitability are tempered by lower scores in liquidity, efficiency and some financial metrics, presenting a balanced picture of strength and areas for improvement.

Latest Report

View All
Audited Standalone Financial Results for the Quarter and Year Ended March 31, 2026

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Syngene International Ltd Health Insights
Health Score : 7.44Health Score : 7.44

Syngene International Ltd demonstrates a mixed financial performance. The company showcases robust solvency, growth, coverage, and profitability, indicating financial stability and efficient management. Its growth is fueled by increasing revenues and operating profits. However, liquidity and efficiency pose challenges. The company's financial ratios also indicate areas needing attention. While the company excels in key areas, addressing these weaknesses could enhance its overall financial health and competitive position in the healthcare services sector. Syngene's high scores in solvency, growth, coverage, and profitability are tempered by lower scores in liquidity, efficiency and some financial metrics, presenting a balanced picture of strength and areas for improvement.

Latest Report

View All
Audited Standalone Financial Results for the Quarter and Year Ended March 31, 2026

Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Overvalued

P/E RATIO (TTM)

58.38

Highly Overvalued

Industry Median

28.62

Highly Overvalued
Highly Overvalued

Small Cap Median

27.17

Highly Overvalued

P/E RATIO

56.08

P/B RATIO

3.67

Neutral

Industry Median

3.17

Neutral
Overvalued

Small Cap Median

2.62

Overvalued

P/S RATIO

4.75

Overvalued

Industry Median

3.42

Overvalued
Highly Overvalued

Small Cap Median

2.55

Highly Overvalued

Others

Highly Undervalued

PEG RATIO

-267.02

Highly Undervalued
Overvalued

EV/EBITDA RATIO

19.03

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹440.75 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Quarterly Report29th Apr 26

Audited Standalone Financial Results for the Quarter and Year Ended March 31, 2026

UNDEFINED SENTIMENT

Quarterly Report22nd Jan 26

Quarterly Financial Results Q3 FY 2025-26

NEUTRAL SENTIMENT

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company shows strong and consistent growth. High growth rates in revenue, operating profit, EPS, assets, and net income suggest effective management strategies and market positioning. The company's ability to consistently grow its revenue, profit, and assets signals a promising trajectory. These growth metrics are particularly valuable in the dynamic healthcare services sector.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate19.2322.629.274.392.66
Operating Profit Growth Rate9.5926.787.962.75-12.15
Earnings Per Share (EPS) Growth-2.3717.119.68-2.84-36.25
Asset Growth Rate13.954.85.5110.473.81
Net Income Growth Rate-2.2217.179.91-2.75-36.09
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.80

The company's financial ratios present a mixed picture. The company's adjusted EPS and cash EPS are modest, reflecting moderate earnings. The book value per share is also relatively low. The company's capital expenditures are high, indicating significant investments. The healthcare industry's financial dynamics may influence these ratios.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
WeakDividend Per Share (DPS)Weak
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)10.4211.7212.9611.779.33
Cash Earnings Per Share (Cash EPS)17.6120.723.2823.1119.11
Book Value Per Share82.2490.22105.92117.56120.07
Dividend Per Share (DPS)0.991.271.271.231.26
Capital Expenditures (CapEx)476518489770368
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company demonstrates strong profitability. High margins and returns on capital, equity, and assets reflect efficient operations and effective management. The company is generating substantial profit from its sales and investments. The company is creating value for its shareholders. These factors enhance the company's attractiveness to investors in the healthcare services sector.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin16.6318.0416.9416.812.44
Return on Capital Employed (ROCE)1315151410
Return on Equity (ROE)12.0112.8211.9810.56.55
Return on Assets (ROA)13.3516.1616.5315.3813.01
Operating Margin28.5329.529.1528.6924.55
Net Margin15.2114.5314.6213.628.48
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 6.33

The company demonstrates mixed efficiency. Strong inventory management and receivables turnover are offset by less efficient use of fixed assets and capital. The company has efficient inventory and sales management which is useful to reduce holding cost. The less efficient asset turnover ratios may indicate underutilization of resources. These factors could impact the company's competitive positioning within the healthcare services sector.

PoorFixed Asset Turnover RatioPoor
ExcellentInventory Turnover RatioExcellent
GoodReceivables Turnover RatioGood
ExcellentDays Sales in Inventory RatioExcellent
AverageReceivable DaysAverage
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio1.091.21.221.31.24
Inventory Turnover Ratio18.1710.2210.1515.3922.04
Receivables Turnover Ratio5.296.167.197.527.22
Days Sales in Inventory Ratio20.0935.7135.9623.7216.56
Receivable Days6959.2550.7648.5450.55
Capital Turnover Ratio0.640.730.730.70.71
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company exhibits strong coverage ratios. The high interest coverage ratio indicates the company's ability to easily meet its interest obligations. The equity dividend coverage ratio indicates the company can comfortably cover its dividend payments. These factors enhance the company's financial stability and appeal to investors in the healthcare services sector.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio21.1714.214.2113.459.39
Equity Dividend Coverage Ratio109.0910106.25
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits a strong financial position with low debt levels and a high proportion of equity. Low debt ratios suggest a conservative approach to financial leverage. The company's limited reliance on debt reduces its financial risk. These factors could be particularly advantageous in the capital-intensive healthcare services sector, where financial stability is highly valued.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.190.170.110.090.08
Debt to Equity Ratio0.230.20.120.10.09
Equity Ratio0.810.830.890.910.92
Debt To Asset Ratio0.140.130.080.070.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 6.18

The company's liquidity position is mixed, indicating both strengths and weaknesses in its ability to meet short-term obligations. An adequate quick ratio provides some reassurance, signaling the firm's capacity to cover its immediate liabilities with its most liquid assets. The company's current ratio suggests potential challenges in covering current liabilities. While the cash ratio reflects a moderate ability to meet obligations with available cash, the operating cash flow ratio highlights the company's capacity to generate cash from its operations.

WeakCurrent RatioWeak
GoodQuick RatioGood
AverageCash RatioAverage
AverageOperating Cash Flow RatioAverage
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.191.391.391.291.28
Quick Ratio1.071.171.221.191.2
Cash Ratio0.340.360.410.490.47
Operating Cash Flow Ratio0.390.560.750.730.52
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 15 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
2Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
3Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
4Granules India Ltd7.7332.77Highly Overvalued1185.0016.17595.00
5Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
6Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
7Syngene International Ltd7.4456.08Overvalued918.007.55317.00
8Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
9ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
10Ipca Laboratories Ltd6.3335.26Neutral1979.0044.641184.00
11Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
12Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
13Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
14Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
15Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
Management Assessment Summary
OrangeBalanced Management

The management of Syngene International demonstrates mixed performance. Revenue growth is evident over the years, but profitability has fluctuated. The company maintains a reasonable Return on Equity (ROE) and Return on Capital Employed (ROCE), indicating efficient use of capital. However, there is a decline in promoter holding and recent sales growth is concerning.

Category Metric Value Assessment
PROS ROCE 13.76 Efficient use of capital.
CONS Promoter Holding Declining Confidence and alignment are decreasing.
Profit Growth TTM -9% Profit growth is declining.
AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
GoodFinancial Health & PrudenceGood
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Syngene International faces moderate risks. The decline in promoter holding and recent profit growth raise concerns about alignment and future profitability. Operational efficiency, as indicated by working capital management, presents mixed signals. While the company exhibits strengths in debt management and the increase in DII holding indicates positive sentiments and reduction in FII.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
AverageContingent liability evaluationAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Regulatory compliance cost trends

04.

Contingent liability evaluation

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10440.96Bullish
  3. SMA 20443.34Bearish
  4. SMA 50449.50Bearish
  5. EMA 10441.37Bullish
  6. EMA 20443.41Bearish
  7. EMA 50446.79Bearish
  8. DEMA 10439.81Bullish
  9. DEMA 20439.67Bullish
  10. DEMA 50443.87Bearish
  11. TEMA 10440.55Bullish
  12. TEMA 20438.63Bullish
  13. TEMA 50442.01Bearish
  14. MACD-2.72Bullish
  15. ADX11.35Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.77Neutral
  3. CCI-39.47Neutral
  4. ROC 90.05Bullish
  5. ROC 14-1.44Bearish
  6. ROC 25-2.26Bearish
  7. Stoch K33.12Neutral
  8. Stoch D27.75Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper450.98Neutral
  3. BB Middle443.35Neutral
  4. BB Lower435.71Neutral
  5. ATR3.38Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI51.27Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10441.95Bearish
  3. SMA 20447.41Bearish
  4. SMA 50446.98Bearish
  5. EMA 10442.57Bearish
  6. EMA 20445.27Bearish
  7. EMA 50448.16Bearish
  8. DEMA 10439.43Bullish
  9. DEMA 20441.79Bullish
  10. DEMA 50445.00Bearish
  11. TEMA 10439.26Bullish
  12. TEMA 20439.20Bullish
  13. TEMA 50443.43Bearish
  14. MACD-2.91Bearish
  15. ADX13.59Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI41.55Neutral
  3. CCI-77.08Neutral
  4. ROC 9-1.38Bearish
  5. ROC 14-2.19Bearish
  6. ROC 25-1.22Bearish
  7. Stoch K19.86Oversold
  8. Stoch D17.05Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper459.74Neutral
  3. BB Middle447.41Neutral
  4. BB Lower435.07Neutral
  5. ATR4.76Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI58.93Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10447.12Bearish
  3. SMA 20449.23Bearish
  4. SMA 50453.04Bearish
  5. EMA 10445.03Bearish
  6. EMA 20447.24Bearish
  7. EMA 50449.27Bearish
  8. DEMA 10441.73Bullish
  9. DEMA 20444.23Bearish
  10. DEMA 50451.51Bearish
  11. TEMA 10439.47Bullish
  12. TEMA 20443.35Bearish
  13. TEMA 50N/AN/A
  14. MACD-2.45Bearish
  15. ADX22.02Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI43.74Neutral
  3. CCI-124.66Oversold
  4. ROC 9-3.09Bearish
  5. ROC 14-3.05Bearish
  6. ROC 251.05Bullish
  7. Stoch K12.83Oversold
  8. Stoch D10.47Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper461.93Neutral
  3. BB Middle449.22Neutral
  4. BB Lower436.52Neutral
  5. ATR8.49Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.08Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10448.44Bearish
  3. SMA 20450.45Bearish
  4. SMA 50445.70Bearish
  5. SMA 100442.50Bearish
  6. SMA 200543.00Bearish
  7. EMA 10448.60Bearish
  8. EMA 20449.79Bearish
  9. EMA 50449.97Bearish
  10. EMA 100470.84Bearish
  11. EMA 200524.65Bearish
  12. DEMA 10447.06Bearish
  13. DEMA 20449.33Bearish
  14. DEMA 50441.61Bearish
  15. DEMA 100416.59Bullish
  16. DEMA 200428.66Bullish
  17. TEMA 10447.11Bearish
  18. TEMA 20445.65Bearish
  19. TEMA 50459.58Bearish
  20. TEMA 100425.59Bullish
  21. TEMA 200399.46Bullish
  22. MACD-0.70Bearish
  23. ADX19.27Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI45.08Neutral
  3. CCI-75.03Neutral
  4. ROC 14-0.38Bearish
  5. ROC 25-4.95Bearish
  6. Stoch K44.94Neutral
  7. Stoch D52.52Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper470.65Neutral
  3. BB Middle450.45Neutral
  4. BB Lower430.25Neutral
  5. ATR14.67Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI69.89Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20434.66Bullish
  3. SMA 50560.88Bearish
  4. EMA 20465.89Bearish
  5. EMA 50539.90Bearish
  6. DEMA 20416.90Bullish
  7. DEMA 50440.27Bullish
  8. TEMA 20427.11Bullish
  9. TEMA 50399.71Bullish
  10. MACD-32.79Bullish
  11. ADX31.07Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI42.18Neutral
  3. CCI-74.53Neutral
  4. ROC 1414.72Bullish
  5. ROC 25-29.90Bearish
  6. Stoch K46.87Neutral
  7. Stoch D48.98Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper479.07Neutral
  3. BB Middle434.66Neutral
  4. BB Lower390.24Neutral
  5. ATR38.67Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI75.31Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6474.37Bearish
  3. SMA 12562.19Bearish
  4. SMA 24670.69Bearish
  5. EMA 6479.21Bearish
  6. EMA 12541.47Bearish
  7. EMA 24606.64Bearish
  8. DEMA 6420.63Bullish
  9. DEMA 12447.12Bearish
  10. DEMA 24538.66Bearish
  11. TEMA 6420.14Bullish
  12. TEMA 12408.99Bullish
  13. TEMA 24456.15Bearish
  14. MACD-20.76Bearish
  15. ADX19.23Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI43.80Neutral
  3. CCI-159.30Oversold
  4. ROC 25-35.86Bearish
  5. ROC 50-26.04Bearish
  6. Stoch K10.49Oversold
  7. Stoch D33.71Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper929.94Neutral
  3. BB Middle640.58Neutral
  4. BB Lower351.22Neutral
  5. ATR91.39Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI46.97Neutral